Compare AMPY & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPY | APYX |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.8M | 196.4M |
| IPO Year | 2011 | 1995 |
| Metric | AMPY | APYX |
|---|---|---|
| Price | $4.72 | $2.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 905.3K | 116.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | 19.40 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $208,637,000.00 | N/A |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | $23.83 | $11.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.65 | $1.70 |
| 52 Week High | $6.79 | $5.08 |
| Indicator | AMPY | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 31.50 |
| Support Level | $4.53 | $2.83 |
| Resistance Level | $5.07 | $4.29 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 65.85 | 12.40 |
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.